Top Markets
Coin of the day
Burzynski Research Institute, Inc. Burzynski Research Institute, Inc.

Burzynski Research Institute, Inc.

BZYR
Rang in aandelen #39233
Burzynski Research Institute, Inc. engages in the research and development of... Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas.
Aandeelprijs
$0.0045
Laatst gesynchroniseerd: 2026-08-13
Marktkapitalisatie
$591.52K
Verandering (1 dag)
-10.00%
Verandering (1 jaar)
-86.76%
Land
US
Handel Burzynski Research Institute, Inc. (BZYR)

Categorie

Dividendrendementgeschiedenis voor Burzynski Research Institute, Inc. (BZYR)
Het dividendrendement (TTM) van Burzynski Research Institute, Inc. (aandelsymbool: BZYR) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Burzynski Research Institute, Inc. (BZYR) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten